U.S.
Why SELLAS Life Sciences (SLS) Stock Rose 156% on Nov 17: A Phase 3 Filing, Then a $150M Offering
Three U.S. stocks closed up 10% or more on Nov 17. SELLAS (+156%) has a Phase 3 8-K and an offering filing; BILL Holdings has only a press report.